ストックスクリーナーアプリを入手
22.77
4.89%
-1.17
アフターアワーズ：
22.59
-0.18
-0.79%
前日終値:
$23.94
開ける：
$23.81
24時間の取引高:
1.34M
Relative Volume:
1.21
時価総額：
$2.41B
収益：
-
当期純損益:
$-150.70M
株価収益率:
-14.69
EPS:
-1.55
ネットキャッシュフロー:
$-125.67M
1週間 パフォーマンス:
-2.44%
1か月 パフォーマンス:
+0.09%
6か月 パフォーマンス:
+55.11%
1年 パフォーマンス:
-30.35%
1日の値動き範囲:
$22.55
$24.31
1週間の範囲:
$22.55
$25.00
52週間の値動き範囲:
$10.60
$33.38
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
EWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
22.77 | 2.53B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.96 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.36 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
851.42 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.17 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.67 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-25 | 開始されました | Goldman | Neutral |
| 2025-07-30 | 開始されました | Raymond James | Strong Buy |
| 2025-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2025-04-30 | 開始されました | Guggenheim | Buy |
| 2025-04-02 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-01-22 | 開始されました | Stifel | Hold |
| 2024-11-22 | 開始されました | Evercore ISI | Outperform |
| 2024-03-07 | 開始されました | Piper Sandler | Overweight |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2022-08-25 | ダウングレード | Goldman | Neutral → Sell |
| 2022-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-01-28 | 開始されました | Goldman | Neutral |
すべてを表示
Edgewise Therapeutics Inc (EWTX) 最新ニュース
Edgewise Therapeutics (NASDAQ:EWTX) Trading 4% HigherStill a Buy? - MarketBeat
Braidwell LP Raises Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Bellevue Group AG Boosts Stock Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Wall Street analysts’ outlook for Edgewise Therapeutics Inc (EWTX) - setenews.com
Discipline and Rules-Based Execution in EWTX Response - news.stocktradersdaily.com
Schroder Investment Management Group Has $1.98 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Analysts Offer Insights on Healthcare Companies: Nano-X Imaging (NNOX), Edgewise Therapeutics (EWTX) and BioNTech SE (BNTX) - theglobeandmail.com
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.4%Should You Sell? - MarketBeat
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress
XTX Topco Ltd Takes Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Sio Capital Management LLC Acquires New Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400 - MSN
Edgewise Therapeutics reports inducement grants as permitted by the Nasdaq Listing Rules - marketscreener.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Edgewise Therapeutics (EWTX) Stock Analysis Report | Financials & Insights - Benzinga
Handelsbanken Fonder AB Increases Stake in Edgewise Therapeutics, Inc. $EWTX - Defense World
Geode Capital Management LLC Raises Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires 42,753 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Is Edgewise Therapeutics Inc a good long term investmentHigh Dividend Yield Stocks & High Yield Portfolio Growth - earlytimes.in
[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - Stock Titan
Edgewise Therapeutics Appoints Christopher Martin to Board - MSN
Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to "Hold" - MarketBeat
Will Edgewise Therapeutics (EWTX) Gain a Commercial Edge With Its New Board Appointment? - Sahm
Edgewise Therapeutics adds commercial biotech exec Martin to board - Investing.com
Edgewise Therapeutics adds commercial biotech exec Martin to board By Investing.com - Investing.com Nigeria
Edgewise Therapeutics Appoints Christopher Martin as Director - TradingView
[8-K] Edgewise Therapeutics, Inc. Reports Material Event | EWTX SEC FilingForm 8-K - Stock Titan
Edgewise Therapeutics appoints commercial biotech executive Christopher Martin to its Board of Directors - marketscreener.com
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin To Its Board Of Directors - TradingView
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors - WV News
What is the fair value of Edgewise Therapeutics Inc. stock now2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
What recovery options are there for Edgewise Therapeutics Inc.Quarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
Exit strategy if you’re trapped in Edgewise Therapeutics Inc.Earnings Overview Report & Short-Term High Return Ideas - newser.com
How to track smart money flows in Edgewise Therapeutics Inc.July 2025 Breakouts & Safe Entry Point Identification - newser.com
Will Edgewise Therapeutics’ (EWTX) New CFO Mark a Shift in Its Commercial Strategy? - Yahoo Finance
What valuation multiples suggest for Edgewise Therapeutics Inc. stockPrice Action & Free Technical Confirmation Trade Alerts - newser.com
Shareholder Carruthers Files To Sell 70,000 Of Edgewise Therapeutics Inc [EWTX] - TradingView
Edgewise Therapeutics Inc (EWTX) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
1.90%
大文字化:
|
ボリューム (24 時間):